CFR Buys Big in Colombia
CFR Pharmaceuticals has agreed to acquire Colombia’s Laboratorio Franco Colombiano (Lafrancol), it says, in a $562m buy that is uncharacteristically large for the expanding Chilean, and makes it the largest pharmaceuticals company in Colombia. The deal, to be funded with cash and an unspecified amount of debt, is another example of dominant Chilean players expanding across the Andes, with CFR already claiming the position as the largest pharmaceutical company in Chile and Peru. “This acquisition...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.